336 related articles for article (PubMed ID: 23535814)
1. Ischemic colitis with type I interferons used in the treatment of hepatitis C and multiple sclerosis: an evaluation from the food and drug administration adverse event reporting system and review of the literature.
Salk A; Stobaugh DJ; Deepak P; Ehrenpreis ED
Ann Pharmacother; 2013 Apr; 47(4):537-42. PubMed ID: 23535814
[TBL] [Abstract][Full Text] [Related]
2. Ischaemic colitis in rheumatoid arthritis patients receiving tumour necrosis factor-α inhibitors: an analysis of reports to the US FDA Adverse Event Reporting System.
Salk A; Stobaugh DJ; Deepak P; Ehrenpreis ED
Drug Saf; 2013 May; 36(5):329-34. PubMed ID: 23580194
[TBL] [Abstract][Full Text] [Related]
3. T-cell non-Hodgkin's lymphomas reported to the FDA AERS with tumor necrosis factor-alpha (TNF-α) inhibitors: results of the REFURBISH study.
Deepak P; Sifuentes H; Sherid M; Stobaugh D; Sadozai Y; Ehrenpreis ED
Am J Gastroenterol; 2013 Jan; 108(1):99-105. PubMed ID: 23032984
[TBL] [Abstract][Full Text] [Related]
4. Thrombotic events associated with C1 esterase inhibitor products in patients with hereditary angioedema: investigation from the United States Food and Drug Administration adverse event reporting system database.
Gandhi PK; Gentry WM; Bottorff MB
Pharmacotherapy; 2012 Oct; 32(10):902-9. PubMed ID: 23033229
[TBL] [Abstract][Full Text] [Related]
5. Ischaemic colitis during interferon treatment for chronic hepatitis C: report of two cases and literature review.
Kawaguchi T; Ide T; Itou M; Suetsugu M; Yoshioka S; Sakata M; Taniguchi E; Oriishi T; Sumie S; Tsuruta O; Sata M
J Viral Hepat; 2012 Feb; 19(2):e220-4. PubMed ID: 22239522
[TBL] [Abstract][Full Text] [Related]
6. Autoimmune disease complicating antiviral therapy for hepatitis C virus infection.
Wilson LE; Widman D; Dikman SH; Gorevic PD
Semin Arthritis Rheum; 2002 Dec; 32(3):163-73. PubMed ID: 12528081
[TBL] [Abstract][Full Text] [Related]
7. Full results of the Evidence of Interferon Dose-Response-European North American Comparative Efficacy (EVIDENCE) study: a multicenter, randomized, assessor-blinded comparison of low-dose weekly versus high-dose, high-frequency interferon beta-1a for relapsing multiple sclerosis.
Schwid SR; Panitch HS
Clin Ther; 2007 Sep; 29(9):2031-48. PubMed ID: 18035202
[TBL] [Abstract][Full Text] [Related]
8. Topical bovine thrombin: a 21-year review of topical bovine thrombin spontaneous case safety reports submitted to FDA's Adverse Event Reporting System.
Clark JA; Humphries JE; Crean S; Reynolds MW
Pharmacoepidemiol Drug Saf; 2010 Feb; 19(2):107-14. PubMed ID: 20014051
[TBL] [Abstract][Full Text] [Related]
9. Cardiovascular thromboembolic events associated with febuxostat: investigation of cases from the FDA adverse event reporting system database.
Gandhi PK; Gentry WM; Bottorff MB
Semin Arthritis Rheum; 2013 Jun; 42(6):562-6. PubMed ID: 23352248
[TBL] [Abstract][Full Text] [Related]
10. Neurological events with tumour necrosis factor alpha inhibitors reported to the Food and Drug Administration Adverse Event Reporting System.
Deepak P; Stobaugh DJ; Sherid M; Sifuentes H; Ehrenpreis ED
Aliment Pharmacol Ther; 2013 Aug; 38(4):388-96. PubMed ID: 23802849
[TBL] [Abstract][Full Text] [Related]
11. The clinical application of the interferons: a review. NSW Therapeutic Assessment Group.
Stuart-Harris RC; Lauchlan R; Day R
Med J Aust; 1992 Jun; 156(12):869-72. PubMed ID: 1376397
[TBL] [Abstract][Full Text] [Related]
12. Analysis of genotypes and amino acid residues 2209 to 2248 of the NS5A region of hepatitis C virus in relation to the response to interferon-beta therapy.
Kurosaki M; Enomoto N; Murakami T; Sakuma I; Asahina Y; Yamamoto C; Ikeda T; Tozuka S; Izumi N; Marumo F; Sato C
Hepatology; 1997 Mar; 25(3):750-3. PubMed ID: 9049230
[TBL] [Abstract][Full Text] [Related]
13. Ischemic Colitis as a Complication of Medication Use: An Analysis of the Federal Adverse Event Reporting System.
Bielefeldt K
Dig Dis Sci; 2016 Sep; 61(9):2655-65. PubMed ID: 27073073
[TBL] [Abstract][Full Text] [Related]
14. A potent antiviral effect on hepatitis C viral dynamics in serum and peripheral blood mononuclear cells during combination therapy with high-dose daily interferon alfa plus ribavirin and intravenous twice-daily treatment with interferon beta.
Asahina Y; Izumi N; Uchihara M; Noguchi O; Tsuchiya K; Hamano K; Kanazawa N; Itakura J; Miyake S; Sakai T
Hepatology; 2001 Aug; 34(2):377-84. PubMed ID: 11481623
[TBL] [Abstract][Full Text] [Related]
15. Ischemic colitis and complications of constipation associated with the use of alosetron under a risk management plan: clinical characteristics, outcomes, and incidences.
Chang L; Tong K; Ameen V
Am J Gastroenterol; 2010 Apr; 105(4):866-75. PubMed ID: 20197759
[TBL] [Abstract][Full Text] [Related]
16. Evolution of previous sarcoidosis under type 1 interferons given for severe associated disease.
Charlier C; Nunes H; Trinchet JC; Roullet E; Mouthon L; Beaugrand M; Valeyre D
Eur Respir J; 2005 Mar; 25(3):570-3. PubMed ID: 15738304
[TBL] [Abstract][Full Text] [Related]
17. [A trial of new interferon therapy for the patients with chronic hepatitis C resistant to interferon therapy].
Arase Y; Kumada H
Nihon Rinsho; 2001 Jul; 59(7):1309-14. PubMed ID: 11494543
[TBL] [Abstract][Full Text] [Related]
18. Mutations in the nonstructural 5A gene of European hepatitis C virus isolates and response to interferon alfa.
Zeuzem S; Lee JH; Roth WK
Hepatology; 1997 Mar; 25(3):740-4. PubMed ID: 9049228
[TBL] [Abstract][Full Text] [Related]
19. Surveillance for safety after immunization: Vaccine Adverse Event Reporting System (VAERS)--United States, 1991-2001.
Zhou W; Pool V; Iskander JK; English-Bullard R; Ball R; Wise RP; Haber P; Pless RP; Mootrey G; Ellenberg SS; Braun MM; Chen RT
MMWR Surveill Summ; 2003 Jan; 52(1):1-24. PubMed ID: 12825543
[TBL] [Abstract][Full Text] [Related]
20. Clinical parameters to predict response to interferon in relapsing multiple sclerosis.
Fromont A; Debouverie M; Le Teuff G; Quantin C; Binquet C; Moreau T
Neuroepidemiology; 2008; 31(3):150-6. PubMed ID: 18716412
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
